Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

50° Sunny
- Saint Marys, OH (45885)
  Today
  
  A clear sky. Low 26F. WNW winds at 10 to 20 mph, decreasing to less than 5 mph..
  
  Tonight
  
  A clear sky. Low 26F. WNW winds at 10 to 20 mph, decreasing to less than 5 mph.
  
  Updated: November 16, 2025 @ 3:04 pm
- Full Forecast

Site search

Home
News
- Local News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Readers Choice 2025

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

AbbVie (NY:ABBV)

232.36 +0.07 (+0.03%)

Official Closing Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

89 90 Next >

What To Expect From BioMarin Pharmaceutical’s (BMRN) Q4 Earnings

February 18, 2025

Biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) will be reporting results tomorrow afternoon. Here’s what you need to know.

Via StockStory

Trump's Tax Cut Could Add $4.6 Trillion To Deficit, With $48 Billion Tax Relief For Top 100 Firms: Robert Reich ↗

February 18, 2025

Robert Reich has termed Donald Trump's taxation policies as an "absolutely shameless giveaway," that could shoot up deficit to $4.6 trillion.

Via Benzinga

Topics Government

How Is The Market Feeling About AbbVie? ↗

February 17, 2025

Via Benzinga

Is AbbVie Stock a Buy Now? ↗

February 15, 2025

Via The Motley Fool

Looking At AbbVie's Recent Unusual Options Activity ↗

February 03, 2025

Via Benzinga

Why Is Nano-Cap Cancer-Focused Xilio Therapeutics Stock Trading Over 100% On Wednesday? ↗

February 12, 2025

AbbVie and Xilio partner to develop tumor-activated immunotherapies. Xilio's pipeline includes masked T cell engagers for prostate, gastric, and lung cancers.

Via Benzinga

AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies

February 12, 2025

From Xilio Therapeutics, Inc.; AbbVie Inc.

Via GlobeNewswire

Biogen (BIIB) Reports Earnings Tomorrow: What To Expect

February 11, 2025

Biotech company Biogen (NASDAQ:BIIB) will be announcing earnings results tomorrow morning. Here’s what to look for.

Via StockStory

Healthcare And Biotech Playbook As Disruption Gathers Force ↗

February 10, 2025

The XBI was down 1.54% for the week, like off a cliff on Friday from a Wednesday high of $94.82.

Via Talk Markets

Topics ETFs Stocks / Equities

These Stocks Missed on Earnings, But Will Rebound Next Quarter

February 10, 2025

Here are three stocks from companies that missed on earnings but have strong support from analysts that makes each stock a solid Buy for the next year

Via MarketBeat

Gilead Sciences (GILD) Q4 Earnings: What To Expect

February 10, 2025

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) will be announcing earnings results tomorrow afternoon. Here’s what to expect.

Via StockStory

3 Fabulous Dividend Stocks to Buy in February ↗

February 09, 2025

Via The Motley Fool

Vertex Pharmaceuticals (VRTX) Q4 Earnings Report Preview: What To Look For

February 09, 2025

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting results tomorrow afternoon. Here’s what to look for.

Via StockStory

Earnings To Watch: Incyte (INCY) Reports Q4 Results Tomorrow

February 09, 2025

Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) will be reporting earnings tomorrow before the bell. Here’s what to expect.

Via StockStory

3 Dividend Stocks to Double Up on Right Now ↗

February 09, 2025

Via The Motley Fool

These 2 Dividend Stocks Are Absolute Bargains Right Now ↗

February 08, 2025

Via The Motley Fool

3 Top AI-Powered Biotech Stocks to Buy in February ↗

February 06, 2025

Via The Motley Fool

Jim Cramer: This Health Care Stock Is A 'Winner,' Buy Bitcoin Instead Of Coinbase ↗

February 05, 2025

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying AbbVie Inc. (NYSE:ABBV), saying it's “just a gem” and a “winner.” He added, “I can't believe the stock dropped so much.”

Via Benzinga

Exploring the top movers within the S&P500 index during today's session. ↗

February 03, 2025

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Monday.

Via Chartmill

Can Biotech Stocks Survive The Precarious Macro? ↗

February 03, 2025

We were having a nice rally in January 2025 until the reality of tariffs hit on Friday which killed the momentum developing off the mid-January lows.

Via Talk Markets

Topics Stocks / Equities World Trade

Top S&P500 movers in Monday's session ↗

February 03, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Nike To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday ↗

February 03, 2025

Via Benzinga

What You Missed On Friday ↗

February 02, 2025

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.

Via Talk Markets

Topics Stocks / Equities

U.S. Equity Rally Reverses As White House Confirms Imminent Tariffs, Shifting Focus To Fed Policy ↗

February 02, 2025

Under the surface, markets remain preoccupied with the potential impact of tariffs, shifting inflation expectations, and the Federal Reserve’s policy trajectory.

Via Talk Markets

Topics Commodities Economy Futures

Small- To Mid-Cap Biotech Trades Poised For Gains ↗

February 01, 2025

On Monday, we called for a trading bottom in healthcare stocks. We also saw momentum picking for two Health Science sectors: small- to mid-cap biotechs, and MedTech. Here is a closer look at these...

Via Talk Markets

Topics ETFs Stocks / Equities

Want $1 Million in Retirement? 2 Stocks to Buy Now and Hold for Decades. ↗

February 01, 2025

Via The Motley Fool

What's going on in today's session: S&P500 movers ↗

January 31, 2025

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.

Via Chartmill

AbbVie (NYSE:ABBV) Posts Better-Than-Expected Sales In Q4, Stock Soars

January 31, 2025

Pharmaceutical company AbbVie (NYSE:ABBV) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 5.6% year on year to $15.1 billion. Its non-GAAP profit of $2.16 per share...

Via StockStory

Is Big Pharma About To Win? Goldman Sachs Weighs In On 340B And Medicaid Shifts ↗

January 31, 2025

Goldman Sachs analyst Salveen Richter highlights potential benefits for biopharma from 340B reforms, while Medicaid cuts could pose risks for companies with significant drug exposure.

Via Benzinga

AbbVie (ABBV) Q4 2024 Earnings Call Transcript ↗

January 31, 2025

ABBV earnings call for the period ending December 31, 2024.

Via The Motley Fool

Topics Earnings

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

89 90 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Entertainment
Business
Announcements
Obituaries
Local Events
Multimedia
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

The Evening Leader

theeveningleader.com
102 E. Spring St.
Saint Marys, Ohio 45885
Phone: 419-394-7414
Email: editor@theeveningleader.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Saint Marys, OH (45885)

Today

Tonight

AbbVie (NY:ABBV)

All News about AbbVie

Sections

Services

The Evening Leader